0.127
9.35%
-0.0131
After Hours:
.13
0.003
+2.36%
Bluejay Diagnostics Inc stock is traded at $0.127, with a volume of 1.14M.
It is down -9.35% in the last 24 hours and down -31.98% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
See More
Previous Close:
$0.1401
Open:
$0.1359
24h Volume:
1.14M
Relative Volume:
0.58
Market Cap:
$2.10M
Revenue:
-
Net Income/Loss:
$-10.04M
P/E Ratio:
-0.012
EPS:
-10.55
Net Cash Flow:
$-9.34M
1W Performance:
-11.13%
1M Performance:
-31.98%
6M Performance:
-98.02%
1Y Performance:
-99.63%
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Bluejay Diagnostics Inc Stock (BJDX) Latest News
Market Recap Check: Bluejay Diagnostics Inc (BJDX)’s Positive Finish at 0.14, Up/Down 0.86 - The Dwinnex
Should investors be concerned about Bluejay Diagnostics Inc (BJDX)? - US Post News
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Down 9.4% in September - Defense World
Bluejay Diagnostics stock hits 52-week low at $0.13 By Investing.com - Investing.com South Africa
Bluejay Diagnostics stock hits 52-week low at $0.13 - Investing.com
BJDX’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
A Look at Bluejay Diagnostics Inc (BJDX) Shares in the Recent Past Indicates Growth - SETE News
Blue Jays' Zach Pop: Optioned to minors - CBS Sports
Trading Day Triumph: Biodesix Inc (BDSX) Ends at 1.59, a -11.67 Surge/Plunge - The Dwinnex
Are Bluejay Diagnostics Inc (BJDX) shares a good deal now? - US Post News
IT Stock Hits 5% Upper Circuit On Expanding Into Healthcare Industry - Goodreturns
Ratio Examination: Bluejay Diagnostics Inc (BJDX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Blue Cloud Softech Solutions shares hit 5 percent upper circuitCheck details - India.com
Bluejay Diagnostics (NASDAQ:BJDX) versus Plus Therapeutics (NASDAQ:PSTV) Head-To-Head Review - Defense World
Bluetongue vaccine: Virbac announces arrival of Syvazul BTV3 - vet times
155675 (BLD.TO) to Post Q3 2024 Earnings of ($0.20) Per Share, Cormark Forecasts (TSE:BLD) - Defense World
Rs 3546 crore order book & 800 per cent multibagger returns: Civil construction company bags new order worth Rs 221 crore from SSS Realty & Co - Dalal Street Investment Journal
Taking on analysts’ expectations and winning: Bluejay Diagnostics Inc (BJDX) - SETE News
New measures introduced to mitigate spread of BTV - Agriland.co.uk
BJDX underperforms with a -0.79 decrease in share price - US Post News
Deeper Dive: Understanding Bluejay Diagnostics Inc (BJDX) Through its Various Ratios - The Dwinnex
What is Bluejay Diagnostics Inc (BJDX) Stock Return on Shareholders’ Capital? - SETE News
In the Green: Bluejay Diagnostics Inc (BJDX) Closes at 0.15, Up/Down -2.16 from Previous Day - The Dwinnex
Is Bluejay Diagnostics Inc (BJDX) worth investing in despite its undervalued state? - US Post News
BJDX stock plunges to 52-week low of $0.15 amid steep decline - Investing.com Australia
BJDX stock plunges to 52-week low of $0.15 amid steep decline - Investing.com
The growth track for Bluejay Diagnostics Inc (BJDX) has changed recently - SETE News
Bluejay Diagnostics Inc (BJDX)’s Day in Review: Closing at 0.19, Down by -6.65 - The Dwinnex
BJDX’s Stock Journey: What Investors Need to Know About Bluejay Diagnostics Inc’s Performance - The InvestChronicle
Bluejay Diagnostics stock hits 52-week low at $0.2 amid steep decline - Investing.com India
Bluejay Diagnostics extends compliance period for NASDAQ listing - Investing.com
Bluejay Diagnostics extends compliance period for NASDAQ listing By Investing.com - Investing.com UK
Bluejay Diagnostics stock hits 52-week low at $0.2 amid steep decline - Investing.com Canada
Bluejay Diagnostics stock hits 52-week low at $0.2 amid steep decline By Investing.com - Investing.com South Africa
Bluejay Diagnostics stock hits 52-week low at $0.2 amid steep decline - Investing.com UK
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Large Increase in Short Interest - Defense World
There is no doubt that Bluejay Diagnostics Inc (BJDX) ticks all the boxes. - SETE News
Market Update: Bluejay Diagnostics Inc (BJDX) Sees Positive Movement, Closing at 0.21 - The Dwinnex
Market cap of Bluejay Diagnostics Inc [BJDX] reaches 1.44M – now what? - The DBT News
Bluejay Diagnostics increases authorized shares By Investing.com - Investing.com Australia
Bluejay Diagnostics increases authorized shares - Investing.com
It is Poised to be a Bull Market for Bluejay Diagnostics Inc (BJDX) - SETE News
Bluejay Diagnostics Inc (BJDX) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Balance Sheet Dive: Bluejay Diagnostics Inc (BJDX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
BJDX’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Bluejay Diagnostics stock plunges to 52-week low of $0.28 By Investing.com - Investing.com Canada
Bluejay Diagnostics stock plunges to 52-week low of $0.28 - Investing.com
Bluejay Diagnostics stock plunges to 52-week low of $0.28 By Investing.com - Investing.com Australia
Bluejay Diagnostics stock plunges to 52-week low of $0.28 By Investing.com - Investing.com UK
Bluejay Diagnostics Inc (BJDX) Stock: A Year of Market Fluctuations - The InvestChronicle
Should investors be concerned about KULR Technology Group Inc (KULR)? - US Post News
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):